Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 3
2017 5
2018 2
2019 6
2020 7
2021 7
2022 4
2023 4
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L; OPERA I and OPERA II Clinical Investigators. Hauser SL, et al. N Engl J Med. 2017 Jan 19;376(3):221-234. doi: 10.1056/NEJMoa1601277. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002679 Free article. Clinical Trial.
Central and peripheral myeloid-derived suppressor cell-like cells are closely related to the clinical severity of multiple sclerosis.
Ortega MC, Lebrón-Galán R, Machín-Díaz I, Naughton M, Pérez-Molina I, García-Arocha J, Garcia-Dominguez JM, Goicoechea-Briceño H, Vila-Del Sol V, Quintanero-Casero V, García-Montero R, Galán V, Calahorra L, Camacho-Toledano C, Martínez-Ginés ML, Fitzgerald DC, Clemente D. Ortega MC, et al. Acta Neuropathol. 2023 Aug;146(2):263-282. doi: 10.1007/s00401-023-02593-x. Epub 2023 May 27. Acta Neuropathol. 2023. PMID: 37243699 Free PMC article.
Teriflunomide and Epstein-Barr virus in a Spanish multiple sclerosis cohort: in vivo antiviral activity and clinical response.
Domínguez-Mozo MI, González-Suárez I, Villar LM, Costa-Frossard L, Villarrubia N, Aladro Y, Pilo B, Montalbán X, Comabella M, Casanova-Peño I, Martínez-Ginés ML, García-Domínguez JM, García-Martínez MÁ, Arroyo R, Álvarez-Lafuente R. Domínguez-Mozo MI, et al. Front Immunol. 2023 Sep 29;14:1248182. doi: 10.3389/fimmu.2023.1248182. eCollection 2023. Front Immunol. 2023. PMID: 37841253 Free PMC article.
Risk and outcomes of COVID-19 in patients with multiple sclerosis.
Moreno-Torres I, Meca Lallana V, Costa-Frossard L, Oreja-Guevara C, Aguirre C, Alba Suárez EM, Gómez Moreno M, Borrega Canelo L, Sabín Muñoz J, Aladro Y, Cárcamo A, Rodríguez García E, Cuello JP, Monreal E, Sainz de la Maza S, Pérez Parra F, Valenzuela Rojas F, López de Silanes de Miguel C, Casanova I, Martínez Gines ML, Blasco R, Orviz García A, Villar-Guimerans LM, Fernández-Dono G, Elvira V, Santiuste C, Espiño M, García Domínguez JM. Moreno-Torres I, et al. Eur J Neurol. 2021 Nov;28(11):3712-3721. doi: 10.1111/ene.14990. Epub 2021 Jul 18. Eur J Neurol. 2021. PMID: 34152073 Free PMC article.
Abnormal functional connectivity in radiologically isolated syndrome: A resting-state fMRI study.
Benito-León J, Del Pino AB, Aladro Y, Cuevas C, Domingo-Santos Á, Galán Sánchez-Seco V, Labiano-Fontcuberta A, Gómez-López A, Salgado-Cámara P, Costa-Frossard L, Monreal E, Sainz de la Maza S, Matías-Guiu JA, Matías-Guiu J, Delgado-Álvarez A, Montero-Escribano P, Martínez-Ginés ML, Higueras Y, Ayuso-Peralta L, Malpica N, Melero H. Benito-León J, et al. Mult Scler. 2023 Oct;29(11-12):1393-1405. doi: 10.1177/13524585231195851. Epub 2023 Sep 29. Mult Scler. 2023. PMID: 37772510 Free PMC article.
Short-chain fatty acids during pregnancy in multiple sclerosis: A prospective cohort study.
Cuello JP, Martínez Ginés ML, García Domínguez JM, Tejeda-Velarde A, Lozano Ros A, Higueras Y, Meldaña Rivera A, Goicochea Briceño H, Garcia-Tizon S, de León-Luis J, Medina Heras S, Fernández Velasco JI, Pérez-Pérez S, García-Martínez MÁ, Pardo-Rodríguez B, Domínguez-Mozo MI, García-Calvo E, Estévez H, Luque-García JL, Villar LM, Alvarez-Lafuente R. Cuello JP, et al. Eur J Neurol. 2022 Mar;29(3):895-900. doi: 10.1111/ene.15150. Epub 2021 Nov 1. Eur J Neurol. 2022. PMID: 34662474
Early predictive risk factors for dimethyl fumarate-associated lymphopenia in patients with multiple sclerosis.
Sainz de la Maza S, Sabin Muñoz J, Pilo de la Fuente B, Thuissard I, Andreu-Vázquez C, Galán Sánchez-Seco V, Salgado-Cámara P, Costa-Frossard L, Monreal E, Ayuso-Peralta L, García-Vasco L, García-Domínguez JM, Martínez-Ginés ML, Muñoz Fernández C, Díaz-Díaz J, Oreja-Guevara C, Gómez-Moreno M, Martín H, Rubio-Flores L, Blasco MR, Villar-Guimerans LM, Aladro Y; Dimethyl Fumarate Study Group. Sainz de la Maza S, et al. Mult Scler Relat Disord. 2022 Mar;59:103669. doi: 10.1016/j.msard.2022.103669. Epub 2022 Feb 4. Mult Scler Relat Disord. 2022. PMID: 35150979
Perception of Stigma in Patients with Neuromyelitis Optica Spectrum Disorder.
Meca-Lallana JE, Prefasi D, Pérez-Miralles F, Forero L, Sepúlveda M, Calles C, Martínez-Ginés ML, González-Suárez I, Boyero S, Romero-Pinel L, Sempere ÁP, Meca-Lallana V, Querol L, Costa-Frossard L, de Castro-Trapiello H, Canal N, Maurino J. Meca-Lallana JE, et al. Among authors: martinez gines ml. Patient Prefer Adherence. 2021 Apr 12;15:713-719. doi: 10.2147/PPA.S305707. eCollection 2021. Patient Prefer Adherence. 2021. PMID: 33880015 Free PMC article.
Perception of stigma in patients with primary progressive multiple sclerosis.
Pérez-Miralles F, Prefasi D, García-Merino A, Ara JR, Izquierdo G, Meca-Lallana V, Gascón F, Martínez-Ginés ML, Ramió-Torrentà L, Costa-Frossard L, Fernández Ó, Moreno-García S, Maurino J, Casanova-Estruch B. Pérez-Miralles F, et al. Among authors: martinez gines ml. Mult Scler J Exp Transl Clin. 2019 May 22;5(2):2055217319852717. doi: 10.1177/2055217319852717. eCollection 2019 Apr-Jun. Mult Scler J Exp Transl Clin. 2019. PMID: 31205741 Free PMC article.
38 results